v3.25.2
Net Loss per Common Share
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Basic and diluted earnings per common share:    
Net Loss per Common Share

4. Net Loss per Common Share

 

The Company calculates net loss per common share in accordance with ASC 260 “Earnings Per Share” (“ASC 260”). Basic and diluted net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period.

 

The following potentially dilutive securities have not been included in the computation of diluted net loss per share for the three months ended March 31, 2025 and 2024, as the result would be anti-dilutive:

 

   March 31,   March 31, 
   2025   2024 
Stock options   

25,259

    619 
Restricted Stock Units   136    187 
6% convertible exchangeable preferred stock   0    0 
Series A preferred stock   2    2 
Series D preferred stock   162,588     
Series E preferred stock   458,333     
Common stock warrants   101,905    2,648 
Total shares excluded from calculation   748,224    3,456 

 

15. Net Loss Per Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:

 

   2024   2023 
   Years ended December 31, 
   2024   2023 
Numerator:          
Net loss  $(11,212)  $(22,555)
Dividend on convertible exchangeable preferred shares       (201)
Net loss attributable to common shareholders  $(11,212)  $(22,756)
           
Denominator:          
Weighted-average number of common shares used in loss per share – basic and diluted   22,314    3,545 
Loss per share - basic and diluted  $(502.46)  $(6,419.07)

 

 

Potential dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

   December 31,   December 31, 
   2024   2023 
Stock options   494    595 
Restricted Stock Units   164    144 
6% convertible exchangeable preferred stock   0    0 
Series A preferred stock   2    2 
Series B preferred stock       165 
Common stock warrants   117,182    2,648 
Total shares excluded from calculation   117,842    3,554